Nuvalent, Inc. Financials

NUVL

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 6 available years

Income Statement	DEC 2025	DEC 2024	DEC 2023	DEC 2022 ~2.3:1 split	DEC 2021 ~7.6:1 split
General & Administrative	$107	$63	$36	$22	$10
Research & Development	$307	$218	$113	$64	$36
Total Operating Expenses	$414	$280	$149	$86	$46
Operating Income	-$414	-$280	-$149	-$86	-$46
Non-Operating
Net Interest Expense	$45	$38	$23	$4	–
Other Non-Operating Income (Expense)	-$55	-$18	-$0	-$0	-$1
EBT (Earnings Before Tax)	-$425	-$260	-$126	-$82	–
Income Tax Expense	$1	$1	$0	$0	–
Net Income
Net Income	-$425	-$261	-$126	-$82	-$46
EPS (Basic)	-$5.85	-$3.93	-$2.17	-$1.65	-$2.13
EPS (Diluted)	-$5.85	-$3.93	-$2.17	-$1.65	-$2.13
Weighted Avg Shares (Basic)	72.7M	66.4M	58.2M	49.7M	21.8M
Weighted Avg Shares (Diluted)	72.7M	66.4M	58.2M	49.7M	21.8M
Shares Outstanding	72.7M	66.4M	58.2M	49.7M	21.8M

Nuvalent (NUVL) financials: revenue, profit and margins

Nuvalent (NUVL) generated about n/a in revenue and -$450 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Nuvalent profitable?+

Nuvalent reported about -$450 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

More on NUVL: Overview · Quality scorecard · DCF valuation · Dividend safety

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 7 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 4 Sept 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NUVL

CompareIntrinsic value

SLNOSoleno Therapeutics Inc

No recent price25

OPKOpko Health Inc.

$1.77+2.91%25

IBIOiBio, Inc.

$0.80-2.44%10

LFVNLifeVantage Corporation

$5.97+3.65%73

PAHCPhibro Animal Health Corporation

$39.43+4.73%57

HOOKHookipa Pharma Inc.

No recent price20

VCNXVaccinex, Inc.

$0.70-1.39%10

PTIXProtagenic Therapeutics, Inc.

$0.65+4.84%20

Held by ETFs

NUVL is in 12 US ETFs. The largest of them, with NUVL's weight in each:

Spot a number that looks wrong? Check it in NUVL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NUVL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.